OriginalConsecuencias clínicas y económicas en pacientes que inician tratamiento con Clopidogrel (cas 113665-84-2) de marca vs. genérico: estudio retrospectivo de vida realClinical and economic consequences in patients initiating therapy with Clopidogrel (cas 113665-84-2) brand-name vs. generic: A real-life retrospective study
-
Add time:08/22/2019 Source:sciencedirect.com
ResumenObjetivoEvaluar la persistencia al tratamiento y el uso de los recursos y sus costes en sujetos que inician tratamiento con Clopidogrel (cas 113665-84-2) de marca frente a genérico para el síndrome coronario agudo (SCA) y la enfermedad arterial periférica (EAP).
We also recommend Trading Suppliers and Manufacturers of Clopidogrel (cas 113665-84-2). Pls Click Website Link as below: cas 113665-84-2 suppliers
Prev:Original ArticleWhat is the optimal dose of Clopidogrel (cas 113665-84-2) in paediatric patients?¿Cuál es la dosis óptima de Clopidogrel (cas 113665-84-2) en pacientes pediátricos?☆
Next:Influence of statin treatment on pharmacokinetics and pharmacodynamics of Clopidogrel (cas 113665-84-2) and its metabolites in patients after coronary angiography/angioplasty) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleCarotid Endarterectomy and Concurrent Clopidogrel (cas 113665-84-2) Use: National Practice Patterns in the United States08/29/2019
- Clopidogrel (cas 113665-84-2)☆08/28/2019
- Silver nanoparticles impregnated chitosan layered carbon nanotube as sensor interface for electrochemical detection of Clopidogrel (cas 113665-84-2) in-vitro08/27/2019
- Efficacy and safety of Clopidogrel (cas 113665-84-2) only vs. Clopidogrel (cas 113665-84-2) added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis08/26/2019
- Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel (cas 113665-84-2) Response in Patients Subjected to a Percutaneous Neurointervention08/25/2019
- Original¿Cuál es la dosis óptima de Clopidogrel (cas 113665-84-2) en pacientes pediátricos?What is the optimal dose of Clopidogrel (cas 113665-84-2) in pediatric patients?08/24/2019
- Influence of statin treatment on pharmacokinetics and pharmacodynamics of Clopidogrel (cas 113665-84-2) and its metabolites in patients after coronary angiography/angioplasty08/23/2019
- Original ArticleWhat is the optimal dose of Clopidogrel (cas 113665-84-2) in paediatric patients?¿Cuál es la dosis óptima de Clopidogrel (cas 113665-84-2) en pacientes pediátricos?☆08/21/2019
-
Health and Chemical more >